NCT05080621View on ClinicalTrials.gov

Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2021

Primary Completion Date

November 30, 2025

Study Completion Date

May 31, 2027

Conditions
Gastrointestinal Stromal Tumors
Interventions
DRUG

Ripretinib

50 mg tablets

DRUG

binimetinib

15 mg tablets

Sponsors
All Listed Sponsors
lead

Deciphera Pharmaceuticals, LLC

INDUSTRY